Hester Biosciences submits analyst meet intimation

Hester Biosciences has informed that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has scheduled investor interaction through a teleconference call on Thursday, 5th November 2026 at 2:00 pm (IST), post the announcement of financial results for the quarter and six months period ended 30 September 2026. Details for joining the call are attached.

The above information is a part of company’s filings submitted to BSE.